Hypoxia: A link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease

Seminars in Liver Disease

Volumn 30, Issue 3, 2010, Pages 258-270

  Rosmorduc, Olivier ^a   Housset, Chantal ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Angiogenesis; hepatic stellate cells; hypoxia; liver fibrosis; portal myofibroblasts; vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PLATELET DERIVED GROWTH FACTOR; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CELL DAMAGE; CELL INTERACTION; CELL MATURATION; CELL PERMEABILIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; FIBROGENESIS; HEPATITIS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; LIVER REGENERATION; OXYGEN SENSING; PERICYTE; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; WOUND HEALING;

ANIMALS; CELL HYPOXIA; HEPATIC STELLATE CELLS; HUMANS; HYPERTENSION, PORTAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER REGENERATION; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77955010960     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0030-1255355     Document Type: Review

References (60)

1. Minamishima Y A., Moslehi J, Padera R F., Bronson R T., Liao R, Kaelin W G. Jr. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol 2009 29 5729-5741
2. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000 31 255-260
3. Wiesener M S., Jrgensen J S., Rosenberger C et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003 17 271-273
4. Martin H, Sarsat J P., Lerche-Langrand C et al. Morphological and biochemical integrity of human liver slices in long-term culture: effects of oxygen tension. Cell Biol Toxicol 2002 18 73-85
5. Beaussier M, Wendum D, Fouassier L et al. Adaptative bile duct proliferative response in experimental bile duct ischemia. J Hepatol 2005 42 257-265
6. Fouassier L, Beaussier M, Schiffer E et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol 2007 293 G25-G35
7. Rius J, Guma M, Schachtrup C et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008 453 807-811
8. Rappaport A M., MacPhee P J., Fisher M M., Phillips M J. The scarring of the liver acini (cirrhosis). Tridimensional and microcirculatory considerations. Virchows Arch A Pathol Anat Histopathol 1983 402 107-137
9. Onori P, Morini S, Franchitto A, Sferra R, Alvaro D, Gaudio E. Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats. J Hepatol 2000 33 555-563
10. Arteel G E., Thurman R G., Raleigh J A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 1998 253 743-750
11. Koeppel T A., Trauner M, Baas J C. et al. Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology 1997 26 1085-1091
12. Moon J O., Welch T P., Gonzalez F J., Copple B L. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009 296 G582-G592
13. Rosmorduc O, Wendum D, Corpechot C et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999 155 1065-1073
14. Corpechot C, Barbu V, Wendum D et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002 35 1010-1021
15. Copple B L., Bustamante J J., Welch T P., Kim N D., Moon J O. Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. Liver Int 2009 29 1010-1021
16. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999 94 4177-4185
17. Ankoma-Sey V, Matli M, Chang K B. et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998 17 115-121
18. Yoshiji H, Kuriyama S, Yoshii J et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 2003 52 1347-1354
19. Novo E, Cannito S, Zamara E et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 2007 170 1942-1953
20. Kuwabara K, Ogawa S, Matsumoto M et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A 1995 92 4606-4610
21. Kong T, Eltzschig H K., Karhausen J, Colgan S P., Shelley C S. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci U S A 2004 101 10440-10445
22. Ceradini D J., Gurtner G C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005 15 57-63
23. Manotham K, Tanaka T, Matsumoto M et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004 65 871-880
24. Kimura K, Iwano M, Higgins D F. et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008 295 F1023-F1029
25. Higgins D F., Kimura K, Bernhardt W M. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007 117 3810-3820
26. Sun S, Ning X, Zhang Y et al. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009 75 1278-1287
27. Shimoda K, Mori M, Shibuta K, Banner B F., Barnard G F. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma. Int J Oncol 1999 14 353-359
28. Lee J S., Semela D, Iredale J, Shah V H. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 2007 45 817-825
29. Ankoma-Sey V, Wang Y, Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 2000 31 141-148
30. Aleffi S, Petrai I, Bertolani C et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005 42 1339-1348
31. Bosselut N, Housset C, Marcelo P et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010 10 1017-1028
32. Kinnman N, Hultcrantz R, Barbu V et al. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000 80 697-707
33. Kinnman N, Francoz C, Barbu V et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003 83 163-173
34. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002 36 200-209
35. Bockhorn M, Goralski M, Prokofiev D et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007 138 291-299
36. Masson S, Scotté M, Franois A et al. Changes in growth factor and cytokine mRNA levels after hepatectomy in rat with CCl(4)-induced cirrhosis. Am J Physiol 1999 277 (4 Pt 1) G838-G846
37. Corpechot C, Barbu V, Wendum D et al. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 2002 160 613-620
38. Schiffer E, Housset C, Cacheux W et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005 41 307-314
39. Housset C, Rockey D C., Bissell D M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A 1993 90 9266-9270
40. Rockey D C., Housset C N., Friedman S L. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993 92 1795-1804
41. Rockey D C., Fouassier L, Chung J J. et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998 27 472-480
42. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan J C., Rodés J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005 43 98-103
43. Tugues S, Fernandez-Varo G, Muoz-Luque J et al. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007 46 1919-1926
44. DeBerardinis R J., Lum J J., Hatzivassiliou G, Thompson C B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008 7 11-20
45. Koshiji M, To K K., Hammer S et al. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell 2005 17 793-803
46. Xia X, Lemieux M E., Li W et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci U S A 2009 106 4260-4265
47. Miyoshi A, Kitajima Y, Ide T et al. Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner. Int J Oncol 2006 29 1533-1539
48. Box A H., Demetrick D J. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 2004 25 2325-2335
49. Gwak G Y., Yoon J H., Kim K M., Lee H S., Chung J W., Gores G J. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 2005 42 358-364
50. Kim K W., Bae S K., Lee O H., Bae M H., Lee M J., Park B C. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 1998 58 348-351
51. Baek J H., Jang J E., Kang C M., Chung H Y., Kim N D., Kim K W. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000 19 4621-4631
52. Mazure N M., Nguyen T L., Danan J L. Severe hypoxia specifically downregulates hepatocyte nuclear factor-4 gene expression in HepG2 human hepatoma cells. Tumour Biol 2001 22 310-317
53. Ivan M, Haberberger T, Gervasi D C. et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 2002 99 13459-13464
54. Reiberger T, Angermayr B, Schwabl P et al. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J Hepatol 2009 51 865-873
55. Hennenberg M, Trebicka J, Stark C, Kohistani A Z., Heller J, Sauerbruch T. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 2009 157 258-270
56. Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009 49 1245-1256
57. Kang D H., Hughes J, Mazzali M, Schreiner G F., Johnson R J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001 12 1448-1457
58. Patsenker E, Popov Y, Stickel F et al. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 2009 50 (5) 1501-1511
59. Llovet J M., Ricci S, Mazzaferro V et al, SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 359 378-390
60. Lee K, Qian D Z., Rey S, Wei H, Liu J O., Semenza G L. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc Natl Acad Sci U S A 2009 106 2353-2358